Karolina Sterzyńska

14PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 15, 2026
Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.

|Dec 30, 2025
Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models.

Piotr Stasiak, Justyna Sopel, Julia Maria Lipowicz

|Jun 26, 2025
Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs.

Piotr Stasiak, Justyna Sopel, Artur Płóciennik

|Aug 26, 2023
Cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis.

Natalia Iżycka, Mikołaj Piotr Zaborowski, Łukasz Ciecierski

|Feb 11, 2023
The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients.

Natalia Izycka, Marcin Rucinski, Malgorzata Andrzejewska

|Mar 25, 2022
Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model.

Marta Nowacka, Barbara Ginter-Matuszewska, Monika Świerczewska

Pageof 3

Frequent Collaborators

12 joint publications

Radosław Januchowski

6 joint publications

Monika Świerczewska

5 joint publications

Michał Nowicki

3 joint publications

Marcin Rucinski